Dietary natural products for prevention and treatment of breast cancer

Nutrients

Volumn 9, Issue 7, 2017, Pages

  Li, Ya ^a   Li, Sha ^b   Meng, Xiao ^a   Gan, Ren You ^c   Zhang, Jiao Jiao ^a   Li, Hua Bin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anticancer; Breast cancer; Fruit; Mechanism of action; Soy; Vegetable

Indexed keywords

3 INDOLEMETHANOL; 3,3' DIINDOLYLMETHANE; BENZYL ISOTHIOCYANATE; CISPLATIN; DIALLYL DISULFIDE; DIALLYL TRISULFIDE; DOXORUBICIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; HESPERIDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOXANTRONE; NATURAL PRODUCT; PACLITAXEL; PHENETHYL ISOTHIOCYANATE; PIPERINE; STAT3 PROTEIN; SULFORAPHANE; TAMOXIFEN; THYMOQUINONE; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT;

ANTIOXIDANT ACTIVITY; APOPTOSIS; APPLE; BLACK CUMIN; BONE TURNOVER; BREAST CANCER; CANCER INCIDENCE; CANCER INHIBITION; CANCER RECURRENCE; CANCER RISK; CELL CYCLE ARREST; CEREAL; CHEMOPROPHYLAXIS; CITRUS FRUIT; CYTOTOXICITY; DIETARY INTAKE; DOWN REGULATION; FOOD FREQUENCY QUESTIONNAIRE; FUNGUS; GARCINIA MANGOSTANA; GARLIC; GENE EXPRESSION; GINGER; GRAPE; HUMAN; MANGO; META ANALYSIS (TOPIC); MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; OXIDATIVE STRESS; PHASE 2 CLINICAL TRIAL (TOPIC); PHOSPHOPROTEOMICS; POMEGRANATE; POSTMENOPAUSE; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNAL TRANSDUCTION; SOY FOOD; UPREGULATION; BREAST TUMOR; DIET; DIET THERAPY; DIETARY SUPPLEMENT; FEMALE; PROTECTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL PRODUCTS; BREAST NEOPLASMS; DIET; DIETARY SUPPLEMENTS; FEMALE; HUMANS; PROTECTIVE FACTORS;

EID: 85023758690     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9070728     Document Type: Review

References (283)

1. Torre, L.A.; Bray, F.; Siegel, R.L.; Ferlay, J.; Lortet-Tieulent, J.; Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015, 65, 87–108.
2. Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2017. CA Cancer J. Clin. 2017, 67, 7–30.
3. Reis, J.S.; Pusztai, L. Breast Cancer 2 Gene expression profiling in breast cancer: Classification, prognostication, and prediction. Lancet 2011, 378, 1812–1823.
4. Perou, C.M.; Borresen-Dale, A.L. Systems biology and genomics of breast cancer. Cold Spring Harb Perspect Biol. 2011, 3, doi:10.1101/cshperspect.a003293.
5. Hudis, C.A.; Gianni, L. Triple-negative breast cancer: An unmet medical need. Oncologist 2011, 161, 1–11.
6. Moulder, S.; Hortobagyi, G.N. Advances in the treatment of breast cancer. Clin. Pharmacol. Ther. 2008, 83, 26–36.
7. DeSantis, C.; Ma, J.M.; Bryan, L.; Jemal, A. Breast cancer statistics, 2013. CA Cancer J. Clin. 2014, 64, 52–62.
8. Cazzaniga, M.; Bonanni, B. Breast cancer chemoprevention: Old and new approaches. J. Biomed. Biotechnol. 2012, 2012, 985620.
9. Reddy, K.B. Triple-negative breast cancers: An updated review on treatment options. Curr. Oncol. 2011, 18, E173–E179.
10. Bhadoria, A.S.; Kapil, U.; Sareen, N.; Singh, P. Reproductive factors and breast cancer: A case-control study in tertiary care hospital of North India. Indian J. Cancer 2013, 50, 316–321.
11. Rieder, V.; Salama, M.; Glockner, L.; Muhr, D.; Berger, A.; Tea, M.K.; Pfeiler, G.; Rappaport-Fuerhauser, C.; Gschwantler-Kaulich, D.; Weingartshofer, S. Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers. Mol. Genet. Genom. Med. 2016, 4, 172–177.
12. Sisti, J.S.; Collins, L.C.; Beck, A.H.; Tamimi, R.M.; Rosner, B.A.; Eliassen, A.H. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses’ health studies. Int. J. Cancer 2016, 138, 2346–2356.
13. Ma, H.Y.; Ursin, G.; Xu, X.X.; Lee, E.; Togawa, K.; Duan, L.; Lu, Y.N.; Malone, K.E.; Marchbanks, P.A.; McDonald, J.A. Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: A pooled analysis. Breast Cancer Res. 2017, 19, doi:10.1186/s13058-016-0799-9.
14. Narod, S.A. Hormone replacement therapy and the risk of breast cancer. Nat. Rev. Clin. Oncol. 2011, 8, 669–676.
15. Park, S.Y.; Kolonel, L.N.; Lim, U.; White, K.K.; Henderson, B.E.; Wilkens, L.R. Alcohol consumption and breast cancer risk among women from five ethnic groups with light to moderate intakes: The Multiethnic Cohort Study. Int. J. Cancer 2014, 134, 1504–1510.
16. Park, Y.; O’Brien, K.M.; Zhao, S.S.; Weinberg, C.R.; Baird, D.D.; Sandler, D.P. Gestational diabetes mellitus may be associated with increased risk of breast cancer. Br. J. Cancer 2017, 116, 960–963.
17. Charlot, M.; Castro-Webb, N.; Bethea, T.N.; Bertrand, K.; Boggs, D.A.; Denis, G.V.; Adams-Campbell, L.L.; Rosenberg, L.; Palmer, J.R. Diabetes and breast cancer mortality in Black women. Cancer Cause Control 2017, 28, 61–67.
18. Pierobon, M.; Frankenfeld, C.L. Obesity as a risk factor for triple-negative breast cancers: A systematic review and meta-analysis. Breast Cancer Res. Treat. 2013, 137, 307–314.
19. Jia, Y.J.; Lu, Y.S.; Wu, K.J.; Lin, Q.; Shen, W.; Zhu, M.J.; Huang, S.; Chen, J. Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer Epidemiol. 2013, 37, 197–206.
20. Campeau, P.M.; Foulkes, W.D.; Tischkowitz, M.D. Hereditary breast cancer: New genetic developments, new therapeutic avenues. Hum. Genet. 2008, 124, 31–42.
21. Zheng, J.; Zhou, Y.; Li, Y.; Xu, D.P.; Li, S.; Li, H.B. Spices for prevention and treatment of cancers. Nutrients 2016, 8, 495.
22. Zhou, Y.; Zheng, J.; Li, Y.; Xu, D.P.; Li, S.; Chen, Y.M.; Li, H.B. Natural polyphenols for prevention and treatment of cancer. Nutrients 2016, 8, 515.
23. Zhou, Y.; Li, Y.; Zhou, T.; Zheng, J.; Li, S.; Li, H.B. Dietary natural products for prevention and treatment of liver cancer. Nutrients 2016, 8, 156.
24. Zhang, J.J.; Li, Y.; Zhou, T.; Xu, D.P.; Zhang, P.; Li, S.; Li, H.B. Bioactivities and health benefits of mushrooms mainly from China. Molecules 2016, 21, 938.
25. Zhang, Y.J.; Gan, R.Y.; Li, S.; Zhou, Y.; Li, A.N.; Xu, D.P.; Li, H.B. Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases. Molecules 2015, 20, 21138–21156.
26. Li, F.; Li, S.; Li, H.B.; Deng, G.F.; Ling, W.H.; Xu, X.R. Antiproliferative activities of tea and herbal infusions. Food Funct. 2013, 4, 530–538.
27. Grosso, G.; Bella, F.; Godos, J.; Sciacca, S.; Del Rio, D.; Ray, S.; Galvano, F.; Giovannucci, E.L. Possible role of diet in cancer: Systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nutr. Rev. 2017, 75, 405–419.
28. Farvid, M.S.; Chen, W.Y.; Michels, K.B.; Cho, E.; Willett, W.C.; Eliassen, A.H. Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: Population based cohort study. BMJ Br. Med. J. 2016, 353, doi:10.1136/bmj.i2343.
29. Kim, M.K.; Kim, J.H.; Nam, S.J.; Ryu, S.; Kong, G. Dietary intake of soy protein and tofu in association with breast cancer risk based on a case-control study. Nutr. Cancer 2008, 60, 568–576.
30. Nechuta, S.J.; Caan, B.J.; Chen, W.Y.; Lu, W.; Chen, Z.; Kwan, M.L.; Flatt, S.W.; Zheng, Y.; Zheng, W.; Pierce, J.P. Soy food intake after diagnosis of breast cancer and survival: An in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am. J. Clin. Nutr. 2012, 96, 123–132.
31. Thomson, C.A.; Rock, C.L.; Thompson, P.A.; Caan, B.J.; Cussler, E.; Flatt, S.W.; Pierce, J.P. Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: A secondary analysis from the Women’s Healthy Eating and Living Study. Breast Cancer Res. Treat. 2011, 125, 519–527.
32. Lv, Z.D.; Liu, X.P.; Zhao, W.J.; Dong, Q.; Li, F.N.; Wang, H.B.; Kong, B. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. Int. J. Clin. Exp. Pathol. 2014, 7, 2818– 2824.
33. Gallardo, M.; Calaf, G.M. Curcumin inhibits invasive capabilities through epithelial mesenchymal transition in breast cancer cell lines. Int. J. Oncol. 2016, 49, 1019–1027.
34. Varinska, L.; Gal, P.; Mojzisova, G.; Mirossay, L.; Mojzis, J. Soy and breast cancer: Focus on angiogenesis. Int. J. Mol. Sci. 2015, 16, 11728–11749.
35. Hu, X.J.; Xie, M.Y.; Kluxen, F.M.; Diel, P. Genistein modulates the anti-tumor activity of cisplatin in MCF-7 breast and HT-29 colon cancer cells. Arch. Toxicol. 2014, 88, 625–635.
36. Bonofiglio, D.; Giordano, C.; de Amicis, F.; Lanzino, M.; Ando, S. Natural products as promising antitumoral agents in breast cancer: Mechanisms of action and molecular targets. Mini. Rev. Med. Chem. 2016, 16, 596–604.
37. Zhang, X.L.; Shu, X.O.; Gao, Y.T.; Yang, G.; Li, Q.; Li, H.L.; Jin, F.; Zheng, W. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J. Nutr. 2003, 133, 2874–2878.
38. Mueller, N.T.; Odegaard, A.O.; Gross, M.D.; Koh, W.P.; Yu, M.C.; Yuan, J.M.; Pereira, M.A. Soy intake and risk of type 2 diabetes mellitus in Chinese Singaporeans. Eur. J. Nutr. 2012, 51, 1033–1040.
39. Dong, J.Y.; Qin, L.Q. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: A meta-analysis of prospective studies. Breast Cancer Res. Treat. 2011, 125, 315–323.
40. Grosso, G.; Godos, J.; Lamuela-Raventos, R.; Ray, S.; Micek, A.; Pajak, A.; Sciacca, S.; D’Orazio, N.; Del Rio, D.; Galvano, F. A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: Level of evidence and limitations. Mol. Nutr. Food Res. 2017, 61, doi:10.1002/mnfr.201600930.
41. Chi, F.; Wu, R.; Zeng, Y.C.; Xing, R.; Liu, Y.; Xu, Z.G. Post-diagnosis soy food intake and breast cancer survival: A meta-analysis of cohort studies. Asian Pac. J. Cancer Prev. 2013, 14, 2407–2412.
42. Zhu, Y.Y.; Zhou, L.; Jiao, S.C.; Xu, L.Z. Relationship between soy food intake and breast cancer in China. Asian Pac. J. Cancer Prev. 2011, 12, 2837–2840.
43. Trock, B.J.; Hilakivi-Clarke, L.; Clarke, R. Meta-analysis of soy intake and breast cancer risk. J. Natl. Cancer Inst. 2006, 98, 459–471.
44. Nagata, C. Factors to consider in the association between soy Iisoflavone intake and breast cancer risk. J. Epidemiol. 2010, 20, 83–89.
45. Baglia, M.L.; Zheng, W.; Li, H.L.; Yang, G.; Gao, J.; Gao, Y.T.; Shu, X.O. The association of soy food consumption with the risk of subtype of breast cancers defined by hormone receptor and HER2 status. Int. J. Cancer 2016, 139, 742–748.
46. Wada, K.; Nakamura, K.; Tamai, Y.; Tsuji, M.; Kawachi, T.; Hori, A.; Takeyama, N.; Tanabashi, S.; Matsushita, S.; Tokimitsu, N. Soy isoflavone intake and breast cancer risk in Japan: From the Takayama study. Int. J. Cancer 2013, 133, 952–960.
47. Zhang, Y.F.; Kang, H.B.; Li, B.L.; Zhang, R.M. Positive effects of Ssoy isoflavone food on survival of breast cancer patients in China. Asian Pac. J. Cancer Prev. 2012, 13, 479–482.
48. Ko, K.P.; Kim, S.W.; Ma, S.H.; Park, B.; Ahn, Y.; Lee, J.W.; Lee, M.H.; Kang, E.; Kim, L.S.; Jung, Y. Dietary intake and breast cancer among carriers and noncarriers of BRCA mutations in the Korean Hereditary Breast Cancer Study. Am. J. Clin. Nutr. 2013, 98, 1493–1501.
49. Guo, X.Y.; Cai, Q.Y.; Bao, P.P.; Wu, J.; Wen, W.Q.; Ye, F.; Zheng, W.; Zheng, Y.; Shu, X.O. Long-term soy consumption and tumor tissue microRNA and gene expression in triple-negative breast cancer. Cancer Am. Cancer Soc. 2016, 122, 2544–2551.
50. Conroy, S.M.; Maskarinec, G.; Park, S.Y.; Wilkens, L.R.; Henderson, B.E.; Kolonel, L.N. The effects of soy consumption before diagnosis on breast cancer survival: The multiethnic cohort study. Nutr. Cancer 2013, 65, 527–537.
51. Morimoto, Y.; Maskarinec, G.; Park, S.Y.; Ettienne, R.; Matsuno, R.K.; Long, C.; Steffen, A.D.; Henderson, B.E.; Kolonel, L.N.; Le Marchand, L. Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort. Br. J. Nutr. 2014, 112, 976–983.
52. Woo, H.D.; Park, K.S.; Ro, J.; Kim, J. Differential influence of dietary soy intake on the risk of breast cancer recurrence related to HER2 status. Nutr. Cancer 2012, 64, 198–205.
53. Khan, S.A.; Chatterton, R.T.; Michel, N.; Bryk, M.; Lee, O.; Ivancic, D.; Heinz, R.; Zalles, C.M.; Helenowski, I.B.; Jovanovic, B.D. Soy isoflavone supplementation for breast cancer risk reduction: A randomized phase II trial. Cancer Prev. Res. 2012, 5, 309–319.
54. Yamamoto, S.; Sobue, T.; Sasaki, S.; Kobayashi, M.; Arai, Y.; Uehara, M.; Adlercreutz, H.; Watanabe, S.; Takahashi, T.; Iitoi, Y. Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J. Nutr. 2001, 131, 2741–2747.
55. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69–90.
56. Kuiper, G.G.; Lemmen, J.G.; Carlsson, B.; Corton, J.C.; Safe, S.H.; van der Saag, P.T.; van der Burg, B.; Gustafsson, J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139, 4252–4263.
57. Kuiper, G.G.; Carlsson, B.; Grandien, K.; Enmark, E.; Häggblad, J.; Nilsson, S.; Gustafsson, J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138, 863–870.
58. Pons, D.G.; Nadal-Serrano, M.; Blanquer-Rossello, M.M.; Sastre-Serra, J.; Oliver, J.; Roca, P. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. J. Cell. Biochem. 2014, 115, 949–958.
59. Nadal-Serrano, M.; Pons, D.G.; Sastre-Serra, J.; Blanquer-Rossello, M.D.; Roca, P.; Oliver, J. Genistein modulates oxidative stress in breast cancer cell lines according to ER alpha/ER beta ratio: Effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes. Int. J. Biochem. Cell Biol. 2013, 45, 2045–2051.
60. Pons, D.G.; Nadal-Serrano, M.; Torrens-Mas, M.; Oliver, J.; Roca, P. The phytoestrogen genistein affects breast cancer cells treatment depending on the ER alpha/ER beta ratio. J. Cell. Biochem. 2016, 117, 218–229.
61. Zhang, G.P.; Han, D.; Liu, G.; Gao, S.G.; Cai, X.Q.; Duan, R.H.; Feng, X.S. Effects of soy isoflavone and endogenous oestrogen on breast cancer in MMTV-erbB2 transgenic mice. J. Int. Med. Res. 2012, 40, 2073– 2082.
62. Li, Z.; Li, J.; Mo, B.Q.; Hu, C.Y.; Liu, H.Q.; Qi, H.; Wang, X.R.; Xu, J.D. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol. In Vitro 2008, 22, 1749–1753.
63. Magee, P.J.; Allsopp, P.; Samaletdin, A.; Rowland, I.R. Daidzein, R-(+)equol and S-(−)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2. Eur. J. Nutr. 2014, 53, 345–350.
64. Seol, J.Y.; Youn, Y.N.; Koo, M.; Kim, H.J.; Choi, S.Y. Influence of water-soluble extracts of long-term fermented doenjang on bone metabolism bioactivity and breast cancer suppression. Food Sci. Biotechnol. 2016, 25, 517–524.
65. Zhao, Q.X.; Zhao, M.; Parris, A.B.; Xing, Y.; Yang, X.H. Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells. Int. J. Oncol. 2016, 49, 1203–1210.
66. Chen, J.; Duan, Y.X.; Zhang, X.; Ye, Y.; Ge, B.; Chen, J. Genistein induces apoptosis by the inactivation of the IGF-1R/p-Akt signaling pathway in MCF-7 human breast cancer cells. Food Funct. 2015, 6, 995–1000.
67. Lee, J.H.; Lee, H.J. A daidzein metabolite, 6,7,4′-trihydroxyisoflavone inhibits cellular proliferation through cell cycle arrest and apoptosis induction in MCF10CA1a human breast cancer cells. J. Korean Soc. Appl. Biol. Chem. 2013, 56, 695–700.
68. Stocco, B.; Toledo, K.A.; Fumagalli, H.F.; Bianchini, F.J.; Fortes, V.S.; Fonseca, M.; Toloi, M. Biotransformed soybean extract induces cell death of estrogen-dependent breast cancer cells by modulation of apoptotic proteins. Nutr. Cancer 2015, 67, 612–619.
69. Xie, Q.; Bai, Q.; Zou, L.Y.; Zhang, Q.Y.; Zhou, Y.; Chang, H.; Yi, L.; Zhu, J.D.; Mi, M.T. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells. Genes Chromosomes Cancer 2014, 53, 422–431.
70. Fang, Y.; Zhang, Q.; Wang, X.; Yang, X.; Wang, X.Y.; Huang, Z.; Jiao, Y.C.; Wang, J. Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells. Int. J. Oncol. 2016, 48, 1016–1028.
71. Pan, H.; Zhou, W.B.; He, W.; Liu, X.A.; Ding, Q.; Ling, L.J.; Zha, X.M.; Wang, S. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-kappa B activity via the Notch-1 pathway. Int. J. Mol. Med. 2012, 30, 337–343.
72. Fan, P.H.; Fan, S.J.; Wang, H.; Mao, J.; Shi, Y.; Ibrahim, M.M.; Ma, W.; Yu, X.T.; Hou, Z.H.; Wang, B. Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway. Stem Cell Res. Ther. 2013, 4.
73. Johnson, K.A.; Vemuri, S.; Alsahafi, S.; Castillo, R.; Cheriyath, V. Glycone-rich soy isoflavone extracts promote estrogen receptor positive breast cancer cell growth. Nutr. Cancer 2016, 68, 622–633.
74. Wei, Y.; Gamra, I.; Davenport, A.; Lester, R.; Zhao, L.J.; Wei, Y.D. Genistein induces cytochrome P450 1B1 gene expression and cell proliferation in human breast cancer MCF-7 Ccells. J. Environ. Pathol. Toxicol. Pathol. 2015, 34, 153–159.
75. Andrade, J.E.; Ju, Y.H.; Baker, C.; Doerge, D.R.; Helferich, W.G. Long-term exposure to dietary sources of genistein induces estrogen-independence in the human breast cancer (MCF-7) xenograft model. Mol. Nutr. Food Res. 2015, 59, 413–423.
76. Yang, X.J.; Belosay, A.; Hartman, J.A.; Song, H.X.; Zhang, Y.K.; Wang, W.D.; Doerge, D.R.; Helferich, W.G. Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors. Clin. Exp. Metastasis 2015, 32, 323–333.
77. Gaete, L.; Tchernitchin, A.N.; Bustamante, R.; Villena, J.; Lemus, I.; Gidekel, M.; Cabrera, G.; Astorga, P. Daidzein-estrogen interaction in the rat uterus and its effect on human breast cancer cell growth. J. Med. Food 2012, 15, 1081–1090.
78. Koo, J.; Cabarcas-Petroski, S.; Petrie, J.L.; Diette, N.; White, R.J.; Schramm, L. Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein. BMC Cancer 2015, 15, doi:10.1186/s12885-015-1914-5.
79. Rigalli, J.P.; Tocchetti, G.N.; Arana, M.R.; Villanueva, S.; Catania, V.A.; Theile, D.; Ruiz, M.L.; Weiss, J. The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters. Cancer Lett. 2016, 376, 165–172.
80. Xie, Q.; Chen, M.L.; Qin, Y.; Zhang, Q.Y.; Xu, H.X.; Zhou, Y.; Mi, M.T.; Zhu, J.D. Isoflavone consumption and risk of breast cancer: A dose-response meta-analysis of observational studies. Asia Pac. J. Clin. Nutr. 2013, 22, 118–127.
81. Li, Y.; Zhang, J.J.; Xu, D.P.; Zhou, T.; Zhou, Y.; Li, S.; Li, H.B. Bioactivities and health benefits of wild fruits. Int. J. Mol. Sci. 2016, 17, 1258.
82. Li, F.; Li, S.; Li, H.B.; Deng, G.F.; Ling, W.H.; Wu, S.; Xu, X.R.; Chen, F. Antiproliferative activity of peels, pulps and seeds of 61 fruits. J. Funct. Foods 2013, 5, 1298–1309.
83. Fu, L.; Xu, B.T.; Xu, X.R.; Gan, R.Y.; Zhang, Y.; Xia, E.Q.; Li, H.B. Antioxidant capacities and total phenolic contents of 62 fruits. Food Chem. 2011, 129, 345–350.
84. Fu, L.; Xu, B.T.; Xu, X.R.; Qin, X.S.; Gan, R.Y.; Li, H.B. Antioxidant capacities and total phenolic contents of 56 wild fruits from South China. Molecules 2010, 15, 8602–8617.
85. Xia, E.Q.; Deng, G.F.; Guo, Y.J.; Li, H.B. Biological activities of polyphenols from grapes. Int. J. Mol. Sci. 2010, 11, 622–646.
86. Aune, D.; Chan, D.; Vieira, A.R.; Rosenblatt, D.; Vieira, R.; Greenwood, D.C.; Norat, T. Fruits, vegetables and breast cancer risk: A systematic review and meta-analysis of prospective studies. Breast Cancer Res. Treat. 2012, 134, 479–493.
87. He, J.J.; Gu, Y.T.; Zhang, S.J. Consumption of vegetables and fruits and breast cancer survival: A systematic review and meta-analysis. Sci. Rep. 2017, 7, 599.
88. Wang, L.; Martins-Green, M. The potential of pomegranate and its components for prevention and treatment of breast cancer. Agro. Food Ind. Hi. Tech. 2013, 24, 58–61.
89. Adams, L.S.; Zhang, Y.; Navindra, P.; Seeram, N.P.; Heber, D; Chen, S. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agric. Food Chem. 2006, 54, 980–985.
90. Legua, P.; Forner-Giner, M.A.; Nuncio-Jauregui, N.; Hernandez, F. Polyphenolic compounds, anthocyanins and antioxidant activity of nineteen pomegranate fruits: A rich source of bioactive compounds. J. Funct. Foods 2016, 23, 628–636.
91. Shirode, A.B.; Kovvuru, P.; Chittur, S.V.; Henning, S.M.; Heber, D.; Reliene, R. Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Mol. Carcinog. 2014, 53, 458–470.
92. Mandal, A.; Bishayee, A. Mechanism of breast cancer preventive action of pomegranate: Disruption of estrogen receptor and Wnt/beta-catenin signaling pathways. Molecules 2015, 20, 22315–22328.
93. Costantini, S.; Rusolo, F.; De Vito, V.; Moccia, S.; Picariello, G.; Capone, F.; Guerriero, E.; Castello, G.; Volpe, M.G. Potential anti-inflammatory effects of the hydrophilic fraction of pomegranate (Punica granatum L.) seed oil on breast cancer cell lines. Molecules 2014, 19, 8644–8660.
94. Rocha, A.; Wang, L.; Penichet, M.; Martins-Green, M. Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer. Breast Cancer Res. Treat. 2012, 136, 647–658.
95. Banerjee, N.; Talcott, S.; Safe, S.; Mertens-Talcott, S.U. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: Potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Res. Treat. 2012, 136, 21–34.
96. Dikmen, M.; Ozturk, N.; Ozturk, Y. The antioxidant potency of Punica granatum L. fruit peel reduces cell proliferation and induces apoptosis on breast cancer. J. Med. Food 2011, 14, 1638–1646.
97. Khan, G.N.; Gorin, M.A.; Rosenthal, D.; Pan, Q.T.; Bao, L.W.; Wu, Z.F.; Newman, R.A.; Pawlus, A.D.; Yang, P.Y.; Lansky, E.P. Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integr. Cancer Ther. 2009, 8, 242–253.
98. Adams, L.S.; Zhang, Y.J.; Seeram, N.P.; Heber, D.; Chen, S.A. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev. Res. 2010, 3, 108–113.
99. Mehta, R.; Lansky, E.P. Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur. J. Cancer Prev. 2004, 13, 345–348.
100. Kim, N.D.; Mehta, R.; Yu, W.P.; Neeman, I.; Livney, T.; Amichay, A.; Poirier, D.; Nicholls, P.; Kirby, A.; Jiang, W.G. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res. Treat. 2002, 71, 203–217.
101. Moongkarndi, P.; Kosem, N.; Kaslungka, S.; Luanratana, O.; Pongpan, N.; Neungton, N. Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J. Ethnopharmacol. 2004, 90, 161–166.
102. Yu, L.M.; Zhao, M.M.; Yang, B.; Bai, W.D. Immunomodulatory and anticancer activities of phenolics from Garcinia mangostana fruit pericarp. Food Chem. 2009, 116, 969–973.
103. Gutierrez-Orozco, F.; Failla, M. Biological activities and bioavailability of mangosteen xanthones: A critical review of the current evidence. Nutrients 2013, 5, 3163–3183.
104. Balunas, M.J.; Su, B.; Brueggemeier, R.W.; Kinghorn, A.D. Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. J. Nat. Prod. 2008, 71, 1161–1166.
105. Kritsanawong, S.; Innajak, S.; Imoto, M.; Watanapokasin, R. Antiproliferative and apoptosis induction of alpha-mangostin in T47D breast cancer cells. Int. J. Oncol. 2016, 48, 2155–2165.
106. Kurose, H.; Shibata, M.A.; Iinuma, M.; Otsuki, Y. Alterations in cell cycle and induction of apoptotic cell death in breast cancer cells treated with alpha-mangostin extracted from mangosteen pericarp. J. Biomed. Biotechnol. 2012, 2012, 9p.
107. Moongkarndi, P.; Jaisupa, N.; Samer, J.; Kosem, N.; Konlata, J.; Rodpai, E.; Pongpan, N. Comparison of the biological activity of two different isolates from mangosteen. J. Pharm. Pharmacol. 2014, 66, 1171–1179.
108. Li, P.; Tian, W.X.; Ma, X.F. Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells. Mol. Cancer 2014, 13, 138.
109. Won, Y.S.; Lee, J.H.; Kwon, S.J.; Kim, J.Y.; Park, K.H.; Lee, M.K.; Seo, K.I. Alpha-Mangostin-induced apoptosis is mediated by estrogen receptor alpha in human breast cancer cells. Food Chem. Toxicol. 2014, 66, 158–165.
110. Shibata, M.A.; Iinuma, M.; Morimoto, J.; Kurose, H.; Akamatsu, K.; Okuno, Y.; Akao, Y.; Otsuki, Y. α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation. BMC Med. 2011, 9, 69.
111. Doi, H.; Shibata, M.A.; Shibata, E.; Morimoto, J.; Akao, Y.; Iinuma, M.; Tanigawa, N.; Otsuki, Y. Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer. Anticancer Res. 2009, 29, 2485–2495.
112. Song, J.K.; Bae, J.M. Citrus fruit intake and breast cancer risk: A quantitative systematic review. J. Breast Cancer 2013, 16, 72–76.
113. Park, J.Y.; Shin, M.S.; Kim, S.N.; Kim, H.Y.; Kim, K.H.; Shin, K.S.; Kang, K.S. Polysaccharides from Korean Citrus hallabong peels inhibit angiogenesis and breast cancer cell migration. Int. J. Biol. Macromol. 2016, 85, 522–529.
114. 2 extracts from Citrus hassaku Hort ex Tanaka. J. Korean Soc. Appl. Biol. 2014, 57, 469–472.
115. Alshatwi, A.A.; Shafi, G.; Hasan, T.N.; Al-Hazzani, A.A.; Alsaif, M.A.; Alfawaz, M.A.; Lei, K.Y.; Munshi, A. Apoptosis-mediated inhibition of human breast cancer cell proliferation by lemon citrus extract. Asian Pac. J. Cancer Prev. 2011, 12, 1555–1559.
116. Li, H.Z.; Yang, B.; Huang, J.; Xiang, T.X.; Yin, X.D.; Wan, J.Y.; Luo, F.; Zhang, L.; Li, H.Y.; Ren, G.S. Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting beta-catenin signaling pathway. Toxicol. Lett. 2013, 220, 219–228.
117. Lee, C.J.; Wilson, L.; Jordan, M.A.; Nguyen, V.; Tang, J.; Smiyun, G. Hesperidin suppressed proliferations of both human breast cancer and androgen-dependent prostate cancer cells. Phytother. Res. 2010, 241, S15– S19.
118. Yang, S.F.; Zhang, H.S.; Yang, X.B.; Zhu, Y.L.; Zhang, M. Evaluation of antioxidative and antitumor activities of extracted flavonoids from Pink Lady apples in human colon and breast cancer cell lines. Food Funct. 2015, 6, 3789–3798.
119. Schiavano, G.F.; De Santi, M.; Brandi, G.; Fanelli, M.; Bucchini, A.; Giamperi, L.; Giomaro, G. Inhibition of breast cancer cell proliferation and in vitro tumorigenesis by a new red apple cultivar. PLoS ONE 2015, 10, e135840.
120. Sun, J.; Liu, R.H. Apple phytochemical extracts inhibit proliferation of estrogen-dependent and estrogen-independent human breast cancer cells through cell cycle modulation. J. Agric. Food Chem. 2008, 56, 11661–11667.
121. Yoon, H.; Liu, R.H. Effect of selected phytochemicals and apple extracts on NF-kappa B activation in human breast cancer MCF-7 cells. J. Agric. Food Chem. 2007, 55, 3167–3173.
122. Yoon, H.; Liu, R.H. Effect of 2 alpha-hydroxyursolic acid on NF-kappa B activation induced by TNF-alpha in human breast cancer MCF-7 cells. J. Agric. Food Chem. 2008, 56, 8412–8417.
123. Jiang, X.; Li, T.; Liu, R.H. 2 alpha-Hydroxyursolic acid inhibited cell proliferation and induced apoptosis in MDA-MB-231 human breast cancer cells through the p38/MAPK signal transduction pathway. J. Agric. Food Chem. 2016, 64, 1806–1816.
124. Delphi, L.; Sepehri, H. Apple pectin: A natural source for cancer suppression in 4T1 breast cancer cells in vitro and express p53 in mouse bearing 4T1 cancer tumors, in vivo. Biomed. Pharmacother. 2016, 84, 637– 644.
125. D-glucoside combination on antiproliferative activity in MCF-7 human breast cancer cells in vitro. J. Agric. Food Chem. 2009, 57, 8581– 8586.
126. Sun, T.; Chen, Q.Y.; Wu, L.J.; Yao, X.M.; Sun, X.J. Antitumor and antimetastatic activities of grape skin polyphenols in a murine model of breast cancer. Food Chem. Toxicol. 2012, 50, 3462–3467.
127. Dinicola, S.; Pasqualato, A.; Cucina, A.; Coluccia, P.; Ferranti, F.; Canipari, R.; Catizone, A.; Proietti, S.; D’Anselmi, F.; Ricci, G. Grape seed extract suppresses MDA-MB231 breast cancer cell migration and invasion. Eur. J. Nutr. 2014, 53, 421–431.
128. Hakimuddin, F.; Paliyath, G.; Meckling, K. Treatment of MCF-7 breast cancer cells with a red grape wine polyphenol fraction results in disruption of calcium homeostasis and cell cycle arrest causing selective cytotoxicity. J. Agric. Food Chem. 2006, 54, 7912–7923.
129. Kim, J.A.; Kim, M.R.; Kim, O.; Phuong, N.; Yoon, J.; Oh, W.K.; Bae, K.; Kang, K.W. Amurensin G inhibits angiogenesis and tumor growth of tamoxifen-resistant breast cancer via Pin1 inhibition. Food Chem. Toxicol. 2012, 50, 3625–3634.
130. Burton, L.J.; Smith, B.A.; Smith, B.N.; Loyd, Q.; Nagappan, P.; McKeithen, D.; Wilder, C.L.; Platt, M.O.; Hudson, T.; Odero-Marah, V.A. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. Carcinogenesis 2015, 36, 1019–1027.
131. Banerjee, N.; Kim, H.; Krenek, K.; Talcott, S.T.; Mertens-Talcott, S.U. Mango polyphenolics suppressed tumor growth in breast cancer xenografts in mice: Role of the PI3K/AKT pathway and associated microRNAs. Nutr. Res. 2015, 35, 744–751.
132. Hoang, V.; Pierson, J.T.; Curry, M.C.; Shaw, P.N.; Dietzgen, R.G.; Gidley, M.J.; Roberts-Thomson, S.J.; Monteith, G.R. Polyphenolic contents and the effects of methanol extracts from mango varieties on breast cancer cells. Food Sci. Biotechnol. 2015, 24, 265–271.
133. Abdullah, A.H.; Mohammed, A.S.; Rasedee, A.; Mirghani, M. Oxidative stress-mediated apoptosis induced by ethanolic mango seed extract in cultured estrogen receptor positive breast cancer MCF-7 cells. Int. J. Mol. Sci. 2015, 16, 3528–3536.
134. Abdullah, A.; Mohammed, A.S.; Rasedee, A.; Mirghani, M.; Al-Qubaisi, M.S. Induction of apoptosis and oxidative stress in estrogen receptor-negative breast cancer, MDA-MB231 cells, by ethanolic mango seed extract. BMC Complement. Alter. Med. 2015, 15, 1–7.
135. Nemec, M.J.; Kim, H.; Marciante, A.B.; Barnes, R.C.; Talcott, S.T.; Mertens-Talcott, S.U. Pyrogallol, an absorbable microbial gallotannins-metabolite and mango polyphenols (Mangifera Indica, L.) suppress breast cancer ductal carcinoma in situ proliferation in vitro. Food Funct. 2016, 7, 3825–3833.
136. Gao, Q.H.; Wu, C.S.; Wang, M. The jujube (Ziziphus jujuba Mill.) fruit: A review of current knowledge of fruit composition and health benefits. J. Agric. Food Chem. 2013, 61, 3351–3363.
137. Plastina, P.; Bonofiglio, D.; Vizza, D.; Fazio, A.; Rovito, D.; Giordano, C.; Barone, I.; Catalano, S.; Gabriele, B. Identification of bioactive constituents of Ziziphus jujube fruit extracts exerting antiproliferative and apoptotic effects in human breast cancer cells. J. Ethnopharmacol. 2012, 140, 325–332.
138. Sun, Y.F.; Song, C.K.; Viemstein, H.; Unger, F.; Liang, Z.S. Apoptosis of human breast cancer cells induced by microencapsulated betulinic acid from sour jujube fruits through the mitochondria transduction pathway. Food Chem. 2013, 138, 1998–2007.
139. Abedini, M.R.; Erfanian, N.; Nazem, H.; Jamali, S.; Hoshyar, R. Anti-proliferative and apoptotic effects of Ziziphus jujube on cervical and breast cancer cells. Avicenna J. Phytomed. 2016, 6, 142–148.
140. Somasagara, R.R.; Hegde, M.; Chiruvella, K.K.; Musini, A.; Choudhary, B.; Raghavan, S.C. Extracts of strawberry fruits induce intrinsic pathway of apoptosis in breast cancer cells and inhibits tumor progression in mice. PLoS ONE 2012, 7, e47021.
141. Nguyen, V.; Tang, J.; Oroudjev, E.; Lee, C.J.; Marasigan, C.; Wilson, L.; Ayoub, G. Cytotoxic effects of bilberry extract on MCF7-GFP-Tubulin breast cancer cells. J. Med. Food 2010, 13, 278–285.
142. Li, L.Y.; Adams, L.S.; Chen, S.; Killian, C.; Ahmed, A.; Seeram, N.P. Eugenia Jambolana Lam. berry extract inhibits growth and induces apoptosis of human breast cancer but not non-tumorigenic breast cells. J. Agric. Food Chem. 2009, 57, 826–831.
143. Sun, J.; Liu, R.H. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett. 2006, 241, 124–134.
144. Noratto, G.; Porter, W.; Byrne, D.; Cisneros-Zevallos, L. Polyphenolics from peach (Prunus persica var. Rich Lady) inhibit tumor growth and metastasis of MDA-MB-435 breast cancer cells in vivo. J. Nutr. Biochem. 2014, 25, 796–800.
145. Yu, M.H.; Im, H.G.; Lee, S.O.; Sung, C.; Park, D.C.; Lee, I.S. Induction of apoptosis by immature fruits of Prunus salicina Lindl. cv. Soldam in MDA-MB-231 human breast cancer cells. Int. J. Food Sci. Nutr. 2007, 58, 42–53.
146. Lewandowska, U.; Szewczyk, K.; Owczarek, K.; Hrabec, Z.; Podsedek, A.; Koziolkiewicz, M.; Hrabec, E. Flavanols from Japanese quince (Chaenomeles japonica) fruit inhibit human prostate and breast cancer cell line invasiveness and cause favorable changes in Bax/Bcl-2 mRNA ratio. Nutr. Cancer 2013, 65, 273–285.
147. Dai, Y.M.; Hogan, S.; Schmelz, E.M.; Ju, Y.H.; Canning, C.; Zhou, K.Q. Selective growth inhibition of human breast cancer cells by Graviola fruit extract in vitro and in vivo involving downregulation of EGFR expression. Nutr. Cancer 2011, 63, 795–801.
148. Wang, X.J.; Yuan, S.L.; Wang, J.; Lin, P.; Liu, G.J.; Lu, Y.R.; Zhang, J.; Wang, W.D.; Wei, Y.Q. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo. Toxicol. Appl. Pharm. 2006, 215, 168–178.
149. Dhandayuthapani, S.; Perez, H.D.; Paroulek, A.; Chinnakkannu, P.; Kandalam, U.; Jaffe, M.; Rathinavelu, A. Bromelain-induced apoptosis in GI-101A breast cancer cells. J. Med. Food 2012, 15, 344–349.
150. Liu, X.J.; Lv, K.Z. Cruciferous vegetables intake is inversely associated with risk of breast cancer: A meta-analysis. Breast J. 2013, 22, 309–313.
151. Kang, L.G.; Ding, L.; Wang, Z.Y. Isothiocyanates repress estrogen receptor a expression in breast cancer cells. Oncol. Rep. 2009, 21, 185–192.
152. Tseng, E.; Scott-Ramsay, E.A.; Morris, M.E. Dietary organic isothiocyanates are cytotoxic in human breast cancer MCF-7 and mammary epithelial MCF-12A cell lines. Exp. Biol. Med. 2004, 229, 835–842.
153. Bradlow, H.L. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer. In Vivo 2008, 22, 441–445.
154. Thomson, C.A.; Ho, E.; Strom, M.B. Chemopreventive properties of 3,3′-diindolylmethane in breast cancer: Evidence from experimental and human studies. Nutr. Rev. 2016, 74, 432–443.
155. Sehrawat, A.; St Croix, C.; Baty, C.J.; Watkins, S.; Tailor, D.; Singh, R.P.; Singh, S.V. Inhibition of mitochondrial fusion is an early and critical event in breast cancer cell apoptosis by dietary chemopreventative benzyl isothiocyanate. Mitochondrion 2016, 30, 67–77.
156. Kim, S.H.; Singh, S.V. p53-Independent apoptosis by benzyl isothiocyanate in human breast cancer cells is mediated by suppression of XIAP expression. Cancer Prev. Res. 2010, 3, 718–726.
157. Xiao, D.; Vogel, V.; Singh, S.V. Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak. Mol. Cancer Ther. 2006, 5, 2931–2945.
158. Kim, E.J.; Eom, S.J.; Hong, J.E.; Lee, J.Y.; Choi, M.S.; Park, J. Benzyl isothiocyanate inhibits basal and hepatocyte growth factor-stimulated migration of breast cancer cells. Mol. Cell. Biochem. 2012, 359, 431– 440.
159. Hugo, H.; Ackland, M.L.; Blick, T.; Lawrence, M.G.; Clements, J.A.; Williams, E.D.; Thompson, E.W. Epithelial-mesenchymal and mesenchymal-Epithelial transitions in carcinoma progression. J. Cell. Physiol. 2007, 213, 374–383.
160. Sehrawat, A.; Singh, S.V. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and vxenografted human breast cancer cells. Cancer Prev. Res. 2011, 4, 1107–1117.
161. Xiao, D.; Bommareddy, A.; Kim, S.H.; Sehrawat, A.; Hahm, E.R.; Singh, S.V. Benzyl isothiocyanate causes FoxO1-mediated autophagic death in human breast cancer cells. PLoS ONE 2012, 7, e32597.
162. Kim, S.H.; Nagalingam, A.; Saxena, N.K.; Singh, S.V.; Sharma, D. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3. Carcinogenesis 2011, 32, 359–367.
163. Warin, R.; Xiao, D.; Arlotti, J.A.; Bommareddy, A.; Singh, S.V. Inhibition of human breast cancer xenograft growth by cruciferous vegetable constituent benzyl isothiocyanate. Mol. Carcinogen. 2010, 49, 500–507.
164. Kim, S.H.; Sehrawat, A.; Singh, S.V. Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo. Cancer Prev. Res. 2013, 6, 782–790.
165. Hahm, E.R.; Singh, S.V. Bim contributes to phenethyl isothiocyanate-induced apoptosis in breast cancer cells. Mol. Carcinog. 2012, 51, 465–474.
166. Sarkar, R.; Mukherjee, S.; Biswas, J.; Roy, M. Phenethyl isothiocyanate, by virtue of its antioxidant activity, inhibits invasiveness and metastatic potential of breast cancer cells: HIF-1 alpha as a putative target. Free Radic. Res. 2016, 50, 84–100.
167. Aras, U.; Gandhi, Y.A.; Masso-Welch, P.A.; Morris, M.E. Chemopreventive and anti-angiogenic effects of dietary phenethyl isothiocyanate in an N-methyl nitrosourea-induced breast cancer animal model. Biopharm. Drug Dispos. 2013, 34, 98–106.
168. Moon, Y.J.; Brazeau, D.A.; Morris, M.E. Dietary phenethyl isothiocyanate alters gene expression in human breast cancer cells. EvidBased Complement Alter. Med. 2011, 2011, 1–8.
169. Ramirez, M.C.; Singletary, K. Regulation of estrogen receptor alpha expression in human breast cancer cells by sulforaphane. J. Nutr. Biochem. 2009, 20, 195–201.
170. Pledgie-Tracy, A.; Sobolewski, M.D.; Davidson, N.E. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol. Cancer Ther. 2007, 6, 1013–1021.
171. Kanematsu, S.; Yoshizawa, K.; Uehara, N.; Miki, H.; Sasaki, T.; Kuro, M.; Lai, Y.C.; Kimura, A.; Yuri, T.; Tsubura, A. Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncol. Rep. 2011, 26, 603–608.
172. Lee, Y.R.; Noh, E.M.; Han, J.H.; Kim, J.M.; Hwang, B.M.; Kim, B.S.; Lee, S.H.; Jung, S.H.; Youn, H.J.; Chung, E.Y. Sulforaphane controls TPA-induced MMP-9 expression through the NF-kappa B signaling pathway, but not AP-1, in MCF-7 breast cancer cells. BMB Rep. 2013, 46, 201–206.
173. Yang, M.; Teng, W.D.; Qu, Y.; Wang, H.Y.; Yuan, Q.P. Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1. Breast Cancer Res. Treat. 2016, 158, 277–286.
174. Meeran, S.M.; Patel, S.N.; Tollefsbol, T.O. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS ONE 2010, 5, e11457.
175. Jo, E.H.; Kim, S.H.; Ahn, N.S.; Park, J.S.; Hwang, J.W.; Lee, Y.S.; Kang, K.S. Efficacy of sulforaphane is mediated by p38 MAP kinase and caspase-7 activations in ER-positive and COX-2-expressed human breast cancer cells. Eur. J. Cancer Prev. 2007, 16, 505–510.
176. Meng, Q.H.; Qi, M.; Chen, D.Z.; Yuan, R.Q.; Goldberg, I.D.; Rosen, E.M.; Auborn, K.; Fan, S.J. Suppression of breast cancer invasion and migration by indole-3-carbinol: Associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J. Mol. Med. 2000, 78, 155–165.
177. Ho, J.N.; Jun, W.; Choue, R.; Lee, J. I3C and ICZ inhibit migration by suppressing the EMT process and FAK expression in breast cancer cells. Mol. Med. Rep. 2013, 7, 384–388.
178. Hung, W.C.; Chang, H.C. Indole-3-carbinol inhibits Sp1-induced matrix metalloproteinase-2 expression to attenuate migration and invasion of breast cancer cells. J. Agric. Food Chem. 2009, 57, 76–82.
179. Rahman, K.; Sarkar, F.H.; Banerjee, S.; Wang, Z.W.; Liao, D.; Hong, X.; Sarkar, N.H. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Mol. Cancer Ther. 2006, 5, 2747–2756.
180. Garcia, H.H.; Brar, G.A.; Nguyen, D.; Bjeldanes, L.F.; Firestone, G.L. Indole-3-carbinol (I3C) inhibits cyclin-dependent kinase-2 function in human breast cancer cells by regulating the size distribution, associated cyclin E forms, and subcellular localization of the CDK2 protein complex. J. Biol. Chem. 2005, 280, 8756–8764.
181. Cram, E.J.; Liu, B.D.; Bjeldanes, L.F.; Firestone, G.L. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter. J. Biol. Chem. 2001, 276, 22332–22340.
182. Marconett, C.N.; Sundar, S.N.; Tseng, M.; Tin, A.S.; Tran, K.Q.; Mahuron, K.M.; Bjeldanes, L.F.; Firestone, G.L. Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells. Carcinogenesis 2011, 32, 1315–1323.
183. Rahman, K.; Aranha, O.; Glazyrin, A.; Chinni, S.R.; Sarkar, F.H. Translocation of Bax to mitochondria induces apoptotic cell death in Indole-3-carbinol (I3C) treated breast cancer cells. Oncogene 2000, 19, 5764– 5771.
184. Sarkar, F.H.; Rahman, K.; Li, Y.W. Bax translocation to mitochondria is an important event in inducing apoptotic cell death by indole-3-carbinol (I3C) treatment of breast cancer cells. J. Nutr. 2003, 133S, 2434S-2439S.
185. Marconett, C.N.; Singhal, A.K.; Sundar, S.N.; Firestone, G.L. Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells. Mol. Cell. Endocrinol. 2012, 363, 74–84.
186. Brew, C.T.; Aronchik, I.; Kosco, K.; McCammon, J.; Bjeldanes, L.F.; Firestone, G.L. Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity. Int. J. Cancer 2009, 124, 2294–2302.
187. Ikeda, H.; Old, L.J.; Schreiber, R.D. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002, 13, 95–109.
188. Chatterji, U.; Riby, J.E.; Taniguchi, T.; Bjeldanes, E.L.; Bjeldanes, L.F.; Firestone, G.L. Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells. Carcinogenesis 2004, 25, 1119–1128.
189. Hong, C.; Firestone, G.L.; Bjeldanes, L.F. Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cells. Biochem. Pharmacol. 2002, 63, 1085–1097.
190. Rahman, K.; Sarkar, F.H. Inhibition of nuclear translocation of nuclear factor-kappa B contributes to 3,3′-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res. 2005, 65, 364–371.
191. Nicastro, H.L.; Firestone, G.L.; Bjeldanes, L.F. 3,3′-Diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells. J. Nutr. Biochem. 2013, 24, 1882–1888.
192. Jin, Y.C. 3,3′-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation. Mol. Cell. Biochem. 2011, 358, 345–354.
193. Hong, C.B.; Kim, H.A.; Firestone, G.L.; Bjeldanes, L.F. 3,3′-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 2002, 23, 1297–1305.
194. Gong, Y.X.; Sohn, H.; Xue, L.; Firestone, G.L.; Bjeldanes, L.F. 3,3′-diindolylmethane is a novel mitochondrial H+-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells. Cancer Res. 2006, 66, 4880–4887.
195. Hsu, E.L.; Chen, N.; Westbrook, A.; Wang, F.; Zhang, R.X.; Taylor, R.T.; Hankinson, O. CXCR4 and CXCL12 down-regulation: A novel mechanism for the chemoprotection of 3,3′-diindolylmethane for breast and ovarian cancers. Cancer Lett. 2008, 265, 113–123.
196. Rahman, K.; Li, Y.W.; Wang, Z.W.; Sarkar, S.H.; Sarkar, F.H. Gene expression profiling revealed survivin as a target of 3,3′-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Cancer Res. 2006, 66, 4952–4960.
197. Xue, L.; Firestone, G.L.; Bjeldanes, L.F. DIM stimulates IFN gamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene 2005, 24, 2343–2353.
198. Kapadia, G.J.; Azuine, M.A.; Rao, G.S.; Arai, T.; Iida, A.; Tokuda, H. Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract compared to doxorubicin (Adriamycin) in the human prostate (PC-3) and breast (MCF-7) cancer cell lines. Anti Cancer Agents Med. Chem. 2011, 11, 280–284.
199. Butalla, A.C.; Crane, T.E.; Patil, B.; Wertheim, B.C.; Thompson, P.; Thomson, C.A. Effects of a carrot juice intervention on plasma carotenoids, oxidative stress, and inflammation in overweight breast cancer survivors. Nutr. Cancer 2012, 64, 331–341.
200. Ansari, J.A.; Ahmad, M.K.; Khan, A.R.; Fatima, N.; Khan, H.J.; Rastogi, N.; Mishra, D.P.; Mahdi, A.A. Anticancer and antioxidant activity of Zingiber officinale Roscoe rhizome. Indian J. Exp. Biol. 2016, 54, 767–773.
201. Elkady, A.I.; Abuzinadah, O.A.; Baeshen, N.; Rahmy, T.R. Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale. J. Biomed. Biotechnol. 2012, 2012, 614356.
202. Joo, J.H.; Hong, S.S.; Cho, Y.R.; Seo, D.W. 10-Gingerol inhibits proliferation and invasion of MDA-MB-231 breast cancer cells through suppression of Akt and p38(MAPK) activity. Oncol. Rep. 2016, 35, 779–784.
203. Lee, H.S.; Seo, E.Y.; Kang, N.E.; Kim, W.K. (6)-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J. Nutr. Biochem. 2008, 19, 313–319.
204. Ling, H.; Yang, H.; Tan, S.H.; Chui, W.K.; Chew, E.H. 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-kappa B activation. Brit. J. Pharmacol. 2010, 161, 1763–1777.
205. Hong, B.H.; Wu, C.H.; Yeh, C.T.; Yen, G.C. Invadopodia-associated proteins blockade as a novel mechanism for 6-shogaol and pterostilbene to reduce breast cancer cell motility and invasion. Mol. Nutr. Food Res. 2013, 57, 886–895.
206. Ray, A.; Vasudevan, S.; Sengupta, S. 6-Shogaol inhibits breast cancer cells and stem cell-like spheroids by modulation of Notch signaling pathway and induction of autophagic cell death. PLoS ONE 2015, 10, e1376149.
207. Hsu, Y.L.; Chen, C.Y.; Hou, M.F.; Tsai, E.M.; Jong, Y.J.; Hung, C.H.; Kuo, P.L. 6-Dehydrogingerdione, an active constituent of dietary ginger, induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human breast cancer cells. Mol. Nutr. Food Res. 2010, 54, 1307–1317.
208. Arslan, M.; Ozdemir, L. Oral intake of ginger for chemotherapy-induced nausea and vomiting among women with breast cancer. Clin. J. Oncol. Nurs. 2015, 19, E92–E97.
209. Lua, P.L.; Salihah, N.; Mazlan, N. Effects of inhaled ginger aromatherapy on chemotherapy-induced nausea and vomiting and health-related quality of life in women with breast cancer. Complement. Ther. Med. 2015, 23, 396–404.
210. Yun, H.M.; Ban, J.O.; Park, K.R.; Lee, C.K.; Jeong, H.S.; Han, S.B.; Hong, J.T. Potential therapeutic effects of functionally active compounds isolated from garlic. Pharmacol. Ther. 2014, 142, 183–195.
211. Pourzand, A.; Tajaddini, A.; Pirouzpanah, S.; Asghari-Jafarabadi, M.; Samadi, N.; Ostadrahimi, A.R.; Sanaat, Z. Associations between dietary Allium vegetables and risk of breast cancer: A hospital-based matched case-control study. J. Breast Cancer 2016, 19, 292–300.
212. Nakagawa, H.; Tsuta, K.; Kiuchi, K.; Senzaki, H.; Tanaka, K.; Hioki, K.; Tsubura, A. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 2001, 22, 891–897.
213. Hahm, E.R.; Singh, S.V. Diallyl trisulfide inhibits estrogen receptor-alpha activity in human breast cancer cells. Breast Cancer Res. Treat. 2014, 144, 47–57.
214. Zhang, H.; Wang, K.M.; Lin, G.M.; Zhao, Z.X. Antitumor mechanisms of S-allyl mercaptocysteine for breast cancer therapy. BMC Complement. Alter. Med. 2014, 14, doi:10.1186/1472-6882-14-270.
215. Lee, C.G.; Lee, H.W.; Kim, B.O.; Rhee, D.K.; Pyo, S. Allicin inhibits invasion and migration of breast cancer cells through the suppression of VCAM-1: Regulation of association between p65 and ER-alpha. J. Funct. Foods 2015, 15, 172–185.
216. Altonsy, M.O.; Habib, T.N.; Andrews, S.C. Diallyl disulfide-induced apoptosis in a breast-cancer cell line (MCF-7) may be caused by inhibition of histone deacetylation. Nutr. Cancer 2012, 64, 1251–1260.
217. Lei, X.Y.; Yao, S.Q.; Zu, X.Y.; Huang, Z.X.; Liu, L.J.; Zhong, M.; Zhu, B.Y.; Tang, S.S.; Liao, D.F. Apoptosis induced by diallyl disulfide in human breast cancer cell line MCF-7. Acta Pharmacol. Sin. 2008, 29, 1233– 1239.
218. Xiao, X.S.; Chen, B.; Liu, X.P.; Liu, P.; Zheng, G.P.; Ye, F.; Tang, H.L.; Xie, X.M. Diallyl disulfide suppresses SRC/Ras/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a. PLoS ONE 2014, 9, e11272011.
219. Huang, J.; Yang, B.; Xiang, T.X.; Peng, W.Y.; Qiu, Z.; Wan, J.Y.; Zhang, L.; Li, H.Y.; Li, H.Z.; Ren, G.S. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway. Mol. Nutr. Food Res. 2015, 59, 1063–1075.
220. Na, H.K.; Kim, E.H.; Choi, M.A.; Park, J.M.; Kim, D.H.; Surh, Y.J. Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1. Biochem. Pharmacol. 2012, 84, 1241–1250.
221. Malki, A.; El-Saadani, M.; Sultan, A.S. Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells. Cancer Biol. Ther. 2009, 8, 2174–2184.
222. Liu, Y.P.; Zhu, P.T.; Wang, Y.Y.; Wei, Z.H.; Tao, L.; Zhu, Z.J.; Sheng, X.B.; Wang, S.L.; Ruan, J.S.; Liu, Z.G. Antimetastatic therapies of the polysulfide diallyl Ttrisulfide against triple-negative breast cancer (TNBC) via suppressing MMP2/9 by blocking NF-kappa B and ERK/MAPK signaling pathways. PLoS ONE 2015, 10, e1237814.
223. Kim, S.H.; Kaschula, C.H.; Priedigkeit, N.; Lee, A.V.; Singh, S.V. Forkhead Box Q1 is a novel target of breast cancer stem cell inhibition by diallyl trisulfide. J. Biol. Chem. 2016, 291, 13495–13508.
224. 2 extract of Nigella sativa Linn. against breast cancer cells. J. Med. Food 2013, 16, 1121–1130.
225. Alhazmi, M.I.; Hasan, T.N.; Shafi, G.; Al-Assaf, A.H.; Alfawaz, M.A.; Alshatwi, A.A. Roles of p53 and caspases in induction of apoptosis in MCF-7 breast cancer cells treated with a methanolic extract of Nigella sativa seeds. Asian Pac. J. Cancer Prev. 2014, 15, 9655–9660.
226. Schneider-Stock, R.; Fakhoury, I.H.; Zaki, A.M.; El-Baba, C.O.; Gali-Muhtasib, H.U. Thymoquinone: Fifty years of success in the battle against cancer models. Drug Discov. Today 2014, 19, 18–30.
227. Franke, T.F.; Cantley, L.C. Apoptosis. A bad kinase makes good. Nature 1997, 390, 116–117.
228. Arafa, E.; Zhu, Q.Z.; Shah, Z.I.; Wani, G.; Barakat, B.M.; Racoma, I.; El-Mandy, M.A.; Wani, A.A. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Mutat. Res. 2011, 706, 28–35.
229. Rajput, S.; Kumar, B.; Dey, K.K.; Pal, I.; Parekh, A.; Mandal, M. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. Life Sci. 2013, 93, 783–790.
230. Woo, C.C.; Hsu, A.; Kumar, A.P.; Sethi, G.; Tan, K. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: The role of p38 MAPK and ROS. PLoS ONE 2013, 8, e75356.
231. Woo, C.C.; Loo, S.Y.; Gee, V.; Yap, C.W.; Sethi, G.; Kumar, A.P.; Tan, K. Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-gamma pathway. Biochem. Pharmacol. 2011, 82, 464–475.
232. Yu, S.M.; Kim, S.J. Thymoquinone (TQ) regulates cyclooxygenase-2 expression and prostaglandin E2 production through PI3kinase (PI3K)/p38 kinase pathway in human breast cancer cell line, MDA-MB-231. Anim. Cells Syst. 2012, 16, 274–279.
233. Chou, C.C.; Wu, Y.C.; Wang, Y.F.; Chou, M.J.; Kuo, S.J.; Chen, D.R. Capsaicin-induced apoptosis in human breast cancer MCF-7 cells through caspase-independent pathway. Oncol. Rep. 2009, 21, 665–671.
234. Chang, H.C.; Chen, S.T.; Chien, S.Y.; Kuo, S.J.; Tsai, H.T.; Chen, D.R. Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction. Hum. Exp. Toxicol. 2011, 30, 1657–1665.
235. Thoennissen, N.H.; O’Kelly, J.; Lu, D.; Iwanski, G.B.; La, D.T.; Abbassi, S.; Leiter, A.; Karlan, B.; Mehta, R.; Koeffler, H.P. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene 2010, 29, 285–296.
236. Liu, Z.G.; Zhu, P.T.; Tao, Y.; Shen, C.S.; Wang, S.L.; Zhao, L.G.; Wu, H.Y.; Fan, F.T.; Lin, C.; Chen, C. Cancer-promoting effect of capsaicin on DMBA/TPA-induced skin tumorigenesis by modulating inflammation, Erk and p38 in mice. Food Chem. Toxicol. 2015, 81, 1–8.
237. Yang, J.; Li, T.Z.; Xu, G.H.; Luo, B.B.; Chen, Y.X.; Zhang, T. Low-concentration capsaicin promotes colorectal cancer metastasis by triggering ROS production and modulating Akt/mTOR and STAT-3 pathways. Neoplasma 2013, 60, 364–372.
238. Caprodossi, S.; Amantini, C.; Nabissi, M.; Morelli, M.B.; Farfariello, V.; Santoni, M.; Gismondi, A.; Santoni, G. Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells. Carcinogenesis 2011, 32, 686–694.
239. Greenshields, A.L.; Doucette, C.D.; Sutton, K.M.; Madera, L.; Annan, H.; Yaffe, P.B.; Knickle, A.F.; Dong, Z.M.; Hoskin, D.W. Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Lett. 2015, 357, 129–140.
240. Do, M.T.; Kim, H.G.; Choi, J.H.; Khanal, T.; Park, B.H.; Tran, T.P.; Jeong, T.C.; Jeong, H.G. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. Food Chem. 2013, 141, 2591–2599.
241. Lai, L.H.; Fu, Q.H.; Liu, Y.; Jiang, K.; Guo, Q.M.; Chen, Q.Y.; Yan, B.; Wang, Q.Q.; Shen, J.G. Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacol. Sin. 2012, 33, 523–530.
242. Chryssanthi, D.G.; Lamari, F.N.; Iatrou, G.; Pylara, A.; Karamanos, N.K.; Cordopatis, P. Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res. 2007, 27, 357–362.
243. Chryssanthi, D.G.; Dedes, P.G.; Karamanos, N.K.; Cordopatis, P.; Lamari, F.N. Crocetin inhibits invasiveness of MDA-MB-231 breast cancer cells via downregulation of matrix metalloproteinases. Planta Med. 2011, 77, 146–151.
244. Sajjadi, M.; Bathaie, Z. Comparative study on the preventive effect of saffron carotenoids, crocin and crocetin, in NMU-induced breast cancer in rats. Cell J. 2017, 19, 94–101.
245. Lin, C.; Lin, S.H.; Lin, C.; Liu, Y.; Chen, C.; Chu, C.; Huang, H.; Lin, M. Inhibitory effect of clove methanolic extract and eugenol on dendritic cell functions. J. Funct. Foods 2016, 27, 439–447.
246. Vidhya, N.; Devaraj, S.N. Induction of apoptosis by eugenol in human breast cancer cells. Indian J. Exp. Biol. 2011, 49, 871–878.
247. Al-Sharif, I.; Remmal, A.; Aboussekhra, A. Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation. BMC Cancer 2013, 13, doi:10.1186/1471-2407-13-600.
248. Gonzalez-Vallinas, M.; Molina, S.; Vicente, G.; Sanchez-Martinez, R.; Vargas, T.; Garcia-Risco, M.R.; Fornari, T.; Reglero, G.; de Molina, A.R. Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells. Electrophoresis 2014, 35, 1719–1727.
249. Fuke, Y.; Hishinuma, M.; Namikawa, M.; Oishi, Y.; Matsuzaki, T. Wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate induces apoptosis in human breast cancer by possible involvement of the NF-kappa B pathways. Nutr. Cancer 2014, 66, 879–887.
250. Tang, E.; Rajarajeswaran, J.; Fung, S.Y.; Kanthimathi, M.S. Antioxidant activity of Coriandrum sativum and protection against DNA damage and cancer cell migration. BMC Complement. Alter. Med. 2013, 13, 347, doi:10.1186/1472-6882-13-347.
251. Deng, Y.; Verron, E.; Rohanizadeh, R. Molecular mechanisms of anti-metastatic activity of curcumin. Anticancer Res. 2016, 36, 5639–5647.
252. Wang, Y.W.; Yu, J.Y.; Cui, R.; Lin, J.J.; Ding, X.T. Curcumin in treating breast cancer: A review. JALA J. Lab. Autom. 2016, 21, 723–731.
253. Kumar, P.; Kadakol, A.; Shasthrula, P.K.; Mundhe, N.A.; Jamdade, V.S.; Barua, C.C.; Gaikwad, A.B. Curcumin as an adjuvant to breast cancer treatment. Anti Cancer Agents Med. Chem. 2015, 15, 647–656.
254. Liu, D.W.; Chen, Z.W. The effect of curcumin on breast cancer cells. J. Breast Cancer 2013, 16, 133–137.
255. Hong, S.A.; Kim, K.; Nam, S.J.; Kong, G.; Kim, M.K. A case-control study on the dietary intake of mushrooms and breast cancer risk among Korean women. Int. J. Cancer 2008, 122, 919–923.
256. Li, J.Y.; Zou, L.; Chen, W.; Zhu, B.B.; Shen, N.; Ke, J.T.; Lou, J.; Song, R.R.; Zhong, R.; Miao, X.P. Dietary mushroom intake may reduce the risk of breast cancer: Evidence from a meta-analysis of observational studies. PLoS ONE 2014, 9, e93437.
257. Peng, C.Y.; Fong, P.C.; Yu, C.C.; Tsai, W.C.; Tzeng, Y.M.; Chang, W.W. Methyl antcinate A suppresses the population of cancer stem-like cells in MCF7 human breast cancer cell line. Molecules 2013, 18, 2539–2548.
258. Luo, Z.Y.; Hu, X.P.; Xiong, H.; Qiu, H.; Yuan, X.L.; Zhu, F.; Wang, Y.H.; Zou, Y.M. A polysaccharide from Huaier induced apoptosis in MCF-7 breast cancer cells via down-regulation of MTDH protein. Carbohydr. Polym. 2016, 151, 1027–1033.
259. Shi, X.L.; Zhao, Y.; Jiao, Y.D.; Shi, T.R.; Yang, X.B. ROS-dependent mitochondria molecular mechanisms underlying antitumor activity of Pleurotus abalonus acidic polysaccharides in human breast cancer MCF-7 cells. PLoS ONE 2013, 8, e64266.
260. Sliva, D.; Labarrere, C.; Slivova, V.; Sedlak, M.; Lloyd, F.P.; Ho, N. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem. Biophys. Res. Commun. 2002, 298, 603–612.
261. Choong, Y.K.; Noordin, M.M.; Mohamed, S.; Ali, A.M.; Umar, N.; Tong, C.C. The nature of apoptosis of human breast cancer cells induced by three species of genus Ganoderma, P. Karst. (aphyllophoromycetideae) crude extracts. Int. J. Med. Mushrooms 2008, 10, 115–125.
262. Grube, S.J.; Eng, E.T.; Kao, Y.C.; Kwon, A.; Chen, S. White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J. Nutr. 2001, 131, 3288–3293.
263. Xu, J.K.; Yuan, Q.G.; Luo, P.; Sun, X.L.; Ma, J.C. Pleurotus eous polysaccharides suppress angiogenesis and induce apoptosis via ROS-dependent JNK activation and mitochondrial mediated mechanisms in MCF-7 human breast cancer cells. Bangladesh J. Pharmacol. 2015, 10, 78–86.
264. Aune, D.; Chan, D.; Greenwood, D.C.; Vieira, A.R.; Rosenblatt, D.; Vieira, R.; Norat, T. Dietary fiber and breast cancer risk: A systematic review and meta-analysis of prospective studies. Ann. Oncol. 2012, 23, 1394–1402.
265. Awika, J.M.; Rooney, L.W. Sorghum phytochemicals and their potential impact on human health. Phytochemistry 2004, 65, 1199–1221.
266. Park, J.H.; Darvin, P.; Lim, E.J.; Joung, Y.H.; Hong, D.Y.; Park, E.U.; Park, S.H.; Choi, S.K.; Moon, E.S.; Cho, B.W. Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts. PLoS ONE 2012, 7, e40531.
267. Suganyadevi, P.; Saravanakumar, K.M.; Mohandas, S. The antiproliferative activity of 3-deoxyanthocyanins extracted from red sorghum (Sorghum bicolor) bran through P-53-dependent and Bcl-2 gene expression in breast cancer cell line. Life Sci. 2013, 92, 379–382.
268. Kubatka, P.; Kello, M.; Kajo, K.; Kruzliak, P.; Vybohova, D.; Smejkal, K.; Marsik, P.; Zulli, A.; Gonciova, G.; Mojzis, J. Young barley indicates antitumor effects in experimental breast cancer in vivo and in vitro. Nutr. Cancer 2016, 68, 611–621.
269. Cho, K.; Lee, C.W.; Ohm, J.B. In vitro study on effect of germinated wheat on human breast cancer cells. Cereal Chem. 2016, 93, 647–649.
270. Xue, J.P.; Wang, G.; Zhao, Z.B.; Wang, Q.; Shi, Y. Synergistic cytotoxic effect of genistein and doxorubicin on drug-resistant human breast cancer MCF-7/Adr cells. Oncol. Rep. 2014, 32, 1647–1653.
271. Kaushik, S.; Shyam, H.; Sharma, R.; Balapure, A.K. Genistein synergizes centchroman action in human breast cancer cells. Indian J. Pharmacol. 2016, 48, 637–642.
272. Charalambous, C.; Pitta, C.A.; Constantinou, A.I. Equol enhances tamoxifen’s anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells. BMC Cancer 2013, 13, 238.
273. Taghizadeh, B.; Ghavami, L.; Nikoofar, A.; Goliaei, B. Equol as a potent radiosensitizer in estrogen receptor-positive and -negative human breast cancer cell lines. Breast Cancer 2015, 22, 382–390.
274. Banerjee, S.; Kambhampati, S.; Banerjee, S.K.; Haque, I. Pomegranate sensitizes tamoxifen action in ER-alpha positive breast cancer cells. J. Cell Commun. Signal. 2011, 5, 317–324.
275. McGuire, K.P.; Ngoubilly, N.; Neavyn, M.; Lanza-Jacoby, S. 3,3′-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. J. Surg. Res. 2006, 132, 208– 213.
276. Wang, W.J.; Lv, M.M.; Wang, Y.L.; Zhang, J.G. Development of novel application of 3,3′-diindolylmethane: Sensitizing multidrug resistance human breast cancer cells to gamma-irradiation. Pharm. Biol. 2016, 54, 3164–3168.
277. Rahman, K.W.; Ali, S.; Aboukameel, A.; Sarkar, S.H.; Wang, Z.; Philip, P.A.; Sakr, W.A.; Raz, A. Inactivation of NF-κB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. Mol. Cancer Ther. 2007, 6, 2757–2765.
278. Ganji-Harsini, S.; Khazaei, M.; Rashidi, Z.; Ghanbari, A. Thymoquinone could increase the efficacy of tamoxifen induced apoptosis in human breast cancer cells: An in vitro study. Cell J. 2016, 18, 245–254.
279. Sakalar, C.; Izgi, K.; Iskender, B.; Sezen, S.; Aksu, H.; Cakir, M.; Kurt, B.; Turan, A.; Canatan, H. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer. Tumor Biol. 2016, 37, 4467–4477.
280. Abdelhamed, S.; Yokoyama, S.; Refaat, A.; Ogura, K.; Yagita, H.; Awale, S.; Saiki, I. Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells. Anticancer Res. 2014, 34, 1893–1899.
281. Gollapudi, S.; Ghoneum, M. MGN-3/Biobran, modified arabinoxylan from rice bran, sensitizes human breast cancer cells to chemotherapeutic agent, daunorubicin. Cancer Detect. Prev. 2008, 32, 1–6.
282. Ghoneum, M.; El-Din, N.; Ali, D.A.; El-Dein, M.A. Modified arabinoxylan from rice bran, MGN-3/Biobran, sensitizes metastatic breast cancer cells to paclitaxel in vitro. Anticancer Res. 2014, 34, 81– 87.
283. Bar-Sela, G.; Tsalic, M.; Fried, G.; Goldberg, H. Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: A pilot study. Nutr. Cancer 2007, 58, 43–48.